Skip to main content
. 2021 Dec 16;8(12):e26814. doi: 10.2196/26814

Table 2.

Imputed means, SDs, and effect sizes for quality of life and depressive symptoms.

Groups Baseline (T1),
mean (SD)
6 months (T2),
mean (SD)

9 months (T3),
mean (SD)
Within-group effect
sizes (dz)
Between-group effect
sizes (ds)
T1-T2 T1-T3 T2a T3b
Depressive Symptoms (BDI-IAc)

CGd 25.00 (8.65) 13.62 (9.87) 13.52 (11.49) –1.03 –0.95 –0.10 –0.05

IGe 27.27 (8.67) 14.65 (11.36) 14.07 (11.75) –0.98 –1.08
Quality of life (EuroQol/EQ-5D-3L)

CG 8.25 (1.40) 6.93 (1.80) 6.95 (1.85) –0.69 –0.63 –0.14 –0.10

IG 8.61 (1.68) 7.17 (1.63) 7.12 (1.67) -0.72 –0.65
Quality of life (EQ VAS)

CG 51.34 (17.69) 69.16 (19.96) 69.48 (21.34) 0.60 0.76 0.16 0.10

IG 49.20 (16.61) 65.92 (20.72) 67.39 (21.74) 0.75

0.74

aBetween-group effect sizes comparing CG versus IG at time 2 (T2).

bBetween-group effect sizes comparing CG versus IG at time 3 (T3).

cBDI-IA: Beck Depression Inventory-Spanish version.

dCG: control group (treatment as usual).

eIG: intervention group (ASCENSO + treatment as usual).